. Step 14 of 41
Clinical Stem 3
A patient with right upper lobe adenocarcinoma progressing on biomarker-directed therapy

The Case Continues
The patient was referred to thoracic surgery for possible surgical biopsy to obtain adequate specimens for molecular testing. Based on the patient's tumor anatomy and given the high probability of significant loss of lung function, a surgical resection was not recommended for molecular testing alone in this patient. The patient was re-discussed at the multidisciplinary lung cancer conference.
Each fictitious clinical case scenario is based on a conglomerate of real patient data. Cases have been modified to avoid any possibility for patient identification and to help meet educational objectives. Any resemblance to real persons, living or deceased, is purely coincidental.

The content for these webcasts has been developed by members of the World Association for Bronchology and Interventional Pulmonology. All content was reviewed by an independent multidisciplinary team of experts. Unless otherwise specified, all content is the property of WABIP.
A collaborative project with Pfizer Oncology